(Neo)Adjuvant IDE196 (Darovasertib) in Patients With Localized Ocular Melanoma
NCT 05907954 Brief Summary Neoadjuvant/adjuvant IDE196 (darovasertib) in patients with primary uveal…
Read more arrow_forwardNCT 05907954 Brief Summary Neoadjuvant/adjuvant IDE196 (darovasertib) in patients with primary uveal…
Read more arrow_forwardNCT 06305962 Brief Summary This is a first-in-human, open-label study consisting of…
Read more arrow_forwardNCT 03874884 Brief Summary This phase 1 dose-escalation and dose-expansion study is…
Read more arrow_forwardNCT 05450744 Brief Summary This is an open label, single arm,…
Read more arrow_forwardNCT 05086692 Brief Summary This is a Phase 1/2, multi-center, open-label, dose-escalation…
Read more arrow_forwardNCT 05923008 Brief Summary This is a phase 1/2 multicenter, open-label, first-in-human…
Read more arrow_forwardNCT 06833073 Brief Summary Researchers are looking for new ways to treat…
Read more arrow_forwardNCT 06305767 Brief Summary Researchers are looking for new ways to treat…
Read more arrow_forwardNCT 05763004 Brief Summary The goal of this clinical trial is to…
Read more arrow_forwardNCT 05608876 Brief Summary A Phase II, open label, single arm…
Read more arrow_forward